Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma - PubMed
- ️Mon Jan 01 2007
Comparative Study
. 2007 Dec 15;121(12):2585-90.
doi: 10.1002/ijc.23042.
Affiliations
- PMID: 17721918
- DOI: 10.1002/ijc.23042
Comparative Study
Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma
Takatoshi Shimauchi et al. Int J Cancer. 2007.
Abstract
Adult T-cell leukemia/lymphoma (ATL) is a CD4(+)CD25(+) T-cell malignancy infected with human T-cell leukemia virus type-I (HTLV-I). HTLV-I infection causes the T-cell dysfunction, which contributes to the immunodeficient state of the patients. Programmed death-1 (PD-1) can negatively regulate T-cell response, when its ligand, PD-L1 or PD-L2 mainly expressed on antigen presenting cells, binds to this B7 family receptor. We investigated whether PD-1 is expressed on CD4(+) neoplastic (and/or non-neoplastic) cells or CD8(+) cytotoxic cells in peripheral blood mononuclear cells from 11 patients with ATL. By flow cytometry, we found that the levels of PD-1 expression on both CD4(+)CD25(+) and CD4(+)CD25(-) T-cell populations were increased in ATL patients compared to normal healthy volunteers, while PD-1 levels on CD8(+) T-cells were comparable between the patients and normal subjects. In stimulation with anti-CD3 antibody, the proliferation of PD-1-expressing T-cells from ATL patients was weak when compared to that of PD-1-nonexpressing normal T-cells. In addition to PD-1, PD-L1 was coexpressed on ATL cells in some patients, and PD-L1 expression was enhanced by stimulation with anti-CD3 antibody. Finally, the production of cytokines such as TNF-alpha by ATL cells was restored by blockade of PD-1/PD-L1 interaction. These findings suggest that CD4(+) T-cells are the main PD-1-expressing cells rather than CD8(+) T-cells in ATL patients, and both neoplastic and normal CD4(+) cells are exhausted as a result of PD-1 expression, and additionally PD-L1 expression on the neoplastic cell.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
Cao QH, Xue YL, Wang Y. Cao QH, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Nov;25(11):1020-2. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009. PMID: 19900372 Chinese.
-
Kozako T, Yoshimitsu M, Fujiwara H, Masamoto I, Horai S, White Y, Akimoto M, Suzuki S, Matsushita K, Uozumi K, Tei C, Arima N. Kozako T, et al. Leukemia. 2009 Feb;23(2):375-82. doi: 10.1038/leu.2008.272. Epub 2008 Oct 2. Leukemia. 2009. PMID: 18830259
-
Adult T-cell leukemia derived from S100 beta positive double-negative (CD4- CD8-) T cells.
Suzushima H, Asou N, Hattori T, Takatsuki K. Suzushima H, et al. Leuk Lymphoma. 1994 Apr;13(3-4):257-62. doi: 10.3109/10428199409056289. Leuk Lymphoma. 1994. PMID: 8049648 Review.
-
Nagatani T, Matsuzaki T, Iemoto G, Kim S, Baba N, Miyamoto H, Nakajima H. Nagatani T, et al. Cancer. 1990 Dec 1;66(11):2380-6. doi: 10.1002/1097-0142(19901201)66:11<2380::aid-cncr2820661122>3.0.co;2-h. Cancer. 1990. PMID: 2245393 Review.
Cited by
-
Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma.
Chen X, Wu W, Wei W, Zou L. Chen X, et al. Front Pharmacol. 2022 Apr 26;13:869488. doi: 10.3389/fphar.2022.869488. eCollection 2022. Front Pharmacol. 2022. PMID: 35559250 Free PMC article. Review.
-
Aghajanian S, Teymoori-Rad M, Molaverdi G, Mozhgani SH. Aghajanian S, et al. Front Microbiol. 2020 Dec 22;11:614940. doi: 10.3389/fmicb.2020.614940. eCollection 2020. Front Microbiol. 2020. PMID: 33414779 Free PMC article. Review.
-
Schnorfeil FM, Lichtenegger FS, Emmerig K, Schlueter M, Neitz JS, Draenert R, Hiddemann W, Subklewe M. Schnorfeil FM, et al. J Hematol Oncol. 2015 Jul 30;8:93. doi: 10.1186/s13045-015-0189-2. J Hematol Oncol. 2015. PMID: 26219463 Free PMC article.
-
Matsuyama-Kato A, Murata S, Isezaki M, Kano R, Takasaki S, Ichii O, Konnai S, Ohashi K. Matsuyama-Kato A, et al. Virol J. 2012 May 21;9:94. doi: 10.1186/1743-422X-9-94. Virol J. 2012. PMID: 22612856 Free PMC article.
-
Samimi S, Benoit B, Evans K, Wherry EJ, Showe L, Wysocka M, Rook AH. Samimi S, et al. Arch Dermatol. 2010 Dec;146(12):1382-8. doi: 10.1001/archdermatol.2010.200. Epub 2010 Aug 16. Arch Dermatol. 2010. PMID: 20713771 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials